Last reviewed · How we verify
Rotavirus Vaccine & Breastfeeding — Competitive Intelligence Brief
phase 3
Infectious Diseases
Biologic
Live · refreshed every 30 min
Target snapshot
Rotavirus Vaccine & Breastfeeding (Rotavirus Vaccine & Breastfeeding) — International Centre for Diarrhoeal Disease Research, Bangladesh. The Rotavirus Vaccine works by stimulating the body's immune system to produce antibodies against rotavirus, thereby preventing infection.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Rotavirus Vaccine & Breastfeeding TARGET | Rotavirus Vaccine & Breastfeeding | International Centre for Diarrhoeal Disease Research, Bangladesh | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Rotavirus Vaccine & Breastfeeding CI watch — RSS
- Rotavirus Vaccine & Breastfeeding CI watch — Atom
- Rotavirus Vaccine & Breastfeeding CI watch — JSON
- Rotavirus Vaccine & Breastfeeding alone — RSS
Cite this brief
Drug Landscape (2026). Rotavirus Vaccine & Breastfeeding — Competitive Intelligence Brief. https://druglandscape.com/ci/rotavirus-vaccine-breastfeeding. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab